An Observational Study to Assess Nirsevimab Immunization Rates in Eligible Infants During Their First RSV Season in the Czechia

Clinical trial NCT07634692 · COMPLETED

Trial details

NCT number: NCT07634692
Sponsor: Sanofi
Status: COMPLETED
Study type: OBSERVATIONAL

RSV Immunization

Start date: 2026-06-15
Primary completion: 2026-06-26
Enrollment: 257

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.